These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29259533)

  • 41. [Dissection of differences and similarities of botanical drugs in European Union, US and Canada].
    He Y; Zhao L; Ye Z; Guo Z; Sun H
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2747-50. PubMed ID: 22242441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EU.
    Brévignon-Dodin L
    Biomed Mater Eng; 2010; 20(3):121-6. PubMed ID: 20930319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of nanomedicines in the EU: distilling lessons from the pediatric and the advanced therapy medicinal products approaches.
    Chowdhury N
    Nanomedicine (Lond); 2010 Jan; 5(1):135-42. PubMed ID: 20025470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
    Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
    Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory considerations for generic or biosimilar low molecular weight heparins.
    García-Arieta A; Blázquez A
    Curr Drug Discov Technol; 2012 Jun; 9(2):137-42. PubMed ID: 21838658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan.
    Yano K; Watanabe N; Tsuyuki K; Ikawa T; Kasanuki H; Yamato M
    Regen Ther; 2015 Jun; 1():45-56. PubMed ID: 31589662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory/Scientific Supports for Micro-, Small-, and Medium-Sized Enterprises (SMEs) With Medicinal Products Provided by the PMDA and EMA.
    Kondo H; Shibatsuji M; Yasuda N
    Ther Innov Regul Sci; 2019 Mar; 53(2):193-198. PubMed ID: 29719977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulatory and clinical development to support the approval of advanced therapies medicinal products in Japan.
    Carolina IL; Antònia A; Mercè O; Antonio V
    Expert Opin Biol Ther; 2022 Jul; 22(7):831-842. PubMed ID: 35762253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016.
    Kondo H; Saint-Raymond A; Yasuda N
    Ther Innov Regul Sci; 2018 Mar; 52(2):214-219. PubMed ID: 29714521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of advanced therapy medicinal products in Europe and the role of academia.
    Pearce KF; Hildebrandt M; Greinix H; Scheding S; Koehl U; Worel N; Apperley J; Edinger M; Hauser A; Mischak-Weissinger E; Dickinson AM; Lowdell MW
    Cytotherapy; 2014 Mar; 16(3):289-97. PubMed ID: 24113428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Regulation of Cell Therapy and Gene Therapy Products in Switzerland.
    Bukovac PK; Hauser M; Lottaz D; Marti A; Schmitt I; Schochat T
    Adv Exp Med Biol; 2023; 1430():41-58. PubMed ID: 37526841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan.
    Oye KA; Eichler HG; Hoos A; Mori Y; Mullin TM; Pearson M
    Clin Pharmacol Ther; 2016 Dec; 100(6):626-632. PubMed ID: 27618128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
    Lucas-Samuel S; Ferry N; Trouvin JH
    Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory evaluation of Glybera in Europe - two committees, one mission.
    Melchiorri D; Pani L; Gasparini P; Cossu G; Ancans J; Borg JJ; Drai C; Fiedor P; Flory E; Hudson I; Leufkens HG; Müller-Berghaus J; Narayanan G; Neugebauer B; Pokrotnieks J; Robert JL; Salmonson T; Schneider CK
    Nat Rev Drug Discov; 2013 Sep; 12(9):719. PubMed ID: 23954897
    [No Abstract]   [Full Text] [Related]  

  • 56. Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014.
    Celis P; Ferry N; Hystad M; Schüßler-Lenz M; Doevendans PA; Flory E; Beuneu C; Reischl I; Salmikangas P
    Transfus Med Hemother; 2015 May; 42(3):194-9. PubMed ID: 26195933
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Approval of new biopharmaceuticals 1999-2006: comparison of the US, EU and Japan situations.
    Tsuji K; Tsutani K
    Eur J Pharm Biopharm; 2008 Mar; 68(3):496-502. PubMed ID: 17884403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GMP facilities for manufacturing of advanced therapy medicinal products for clinical trials: an overview for clinical researchers.
    Alici E; Blomberg P
    Curr Gene Ther; 2010 Dec; 10(6):508-15. PubMed ID: 21054243
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulatory considerations for clinical development of cancer vaccines.
    Heelan BT
    Hum Vaccin Immunother; 2014; 10(11):3409-14. PubMed ID: 25625933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.